These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
65 related articles for article (PubMed ID: 20000379)
1. Development of new stereodiverse diaminocyclitols as inhibitors of influenza virus neuraminidase. Cui Y; Jiao Z; Gong J; Yu Q; Zheng X; Quan J; Luo M; Yang Z Org Lett; 2010 Jan; 12(1):4-7. PubMed ID: 20000379 [TBL] [Abstract][Full Text] [Related]
2. Insights from investigating the interaction of oseltamivir (Tamiflu) with neuraminidase of the 2009 H1N1 swine flu virus. Wang SQ; Du QS; Huang RB; Zhang DW; Chou KC Biochem Biophys Res Commun; 2009 Aug; 386(3):432-6. PubMed ID: 19523442 [TBL] [Abstract][Full Text] [Related]
3. A new and rapid genotypic assay for the detection of neuraminidase inhibitor resistant influenza A viruses of subtype H1N1, H3N2, and H5N1. Duwe S; Schweiger B J Virol Methods; 2008 Nov; 153(2):134-41. PubMed ID: 18725246 [TBL] [Abstract][Full Text] [Related]
4. Development of recombinant protein-based influenza vaccine. Expression and affinity purification of H1N1 influenza virus neuraminidase. Dalakouras T; Smith BJ; Platis D; Cox MM; Labrou NE J Chromatogr A; 2006 Dec; 1136(1):48-56. PubMed ID: 17046775 [TBL] [Abstract][Full Text] [Related]
5. Oseltamivir boosts 2009 H1N1 virus infectivity in vitro. Lin X; Zhou J; Zhang Y; Wu J; Zhang F; Li Z; Zhang Y; Bi S; Shu Y; Wang Y Biochem Biophys Res Commun; 2009 Dec; 390(4):1305-8. PubMed ID: 19879239 [TBL] [Abstract][Full Text] [Related]
6. Activity of the neuraminidase inhibitor A-315675 against oseltamivir-resistant influenza neuraminidases of N1 and N2 subtypes. Abed Y; Nehmé B; Baz M; Boivin G Antiviral Res; 2008 Feb; 77(2):163-6. PubMed ID: 17919743 [TBL] [Abstract][Full Text] [Related]
7. QSAR study of flavonoids and biflavonoids as influenza H1N1 virus neuraminidase inhibitors. Mercader AG; Pomilio AB Eur J Med Chem; 2010 May; 45(5):1724-30. PubMed ID: 20116898 [TBL] [Abstract][Full Text] [Related]
8. Different neuraminidase inhibitor susceptibilities of human H1N1, H1N2, and H3N2 influenza A viruses isolated in Germany from 2001 to 2005/2006. Bauer K; Richter M; Wutzler P; Schmidtke M Antiviral Res; 2009 Apr; 82(1):34-41. PubMed ID: 19428593 [TBL] [Abstract][Full Text] [Related]
9. Structure-activity relationship of flavonoids as influenza virus neuraminidase inhibitors and their in vitro anti-viral activities. Liu AL; Wang HD; Lee SM; Wang YT; Du GH Bioorg Med Chem; 2008 Aug; 16(15):7141-7. PubMed ID: 18640042 [TBL] [Abstract][Full Text] [Related]
10. Synthesis of tamiflu and its phosphonate congeners possessing potent anti-influenza activity. Shie JJ; Fang JM; Wang SY; Tsai KC; Cheng YS; Yang AS; Hsiao SC; Su CY; Wong CH J Am Chem Soc; 2007 Oct; 129(39):11892-3. PubMed ID: 17850083 [No Abstract] [Full Text] [Related]
11. Thiosialoside clusters using carbosilane dendrimer core scaffolds as a new class of influenza neuraminidase inhibitors. Sakamoto J; Koyama T; Miyamoto D; Yingsakmongkon S; Hidari KI; Jampangern W; Suzuki T; Suzuki Y; Esumi Y; Hatano K; Terunuma D; Matsuoka K Bioorg Med Chem Lett; 2007 Feb; 17(3):717-21. PubMed ID: 17095224 [TBL] [Abstract][Full Text] [Related]
12. Rapid quantitation of neuraminidase inhibitor drug resistance in influenza virus quasispecies. Lackenby A; Democratis J; Siqueira MM; Zambon MC Antivir Ther; 2008; 13(6):809-20. PubMed ID: 18839782 [TBL] [Abstract][Full Text] [Related]
13. [Active neuraminidase constituents of Polygonum cuspidatum against influenza A(H1N1) influenza virus]. Chen KT; Zhou WL; Liu JW; Zu M; He ZN; Du GH; Chen WW; Liu AL Zhongguo Zhong Yao Za Zhi; 2012 Oct; 37(20):3068-73. PubMed ID: 23311155 [TBL] [Abstract][Full Text] [Related]
14. Sensitivity of influenza viruses to zanamivir and oseltamivir: a study performed on viruses circulating in France prior to the introduction of neuraminidase inhibitors in clinical practice. Ferraris O; Kessler N; Lina B Antiviral Res; 2005 Oct; 68(1):43-8. PubMed ID: 16125799 [TBL] [Abstract][Full Text] [Related]
15. Galactose-conjugates of the oseltamivir pharmacophore--new tools for the characterization of influenza virus neuraminidases. Carbain B; Martin SR; Collins PJ; Hitchcock PB; Streicher H Org Biomol Chem; 2009 Jun; 7(12):2570-5. PubMed ID: 19503932 [TBL] [Abstract][Full Text] [Related]
17. Clinical effectiveness of oseltamivir and zanamivir for treatment of influenza A virus subtype H1N1 with the H274Y mutation: a Japanese, multicenter study of the 2007-2008 and 2008-2009 influenza seasons. Kawai N; Ikematsu H; Hirotsu N; Maeda T; Kawashima T; Tanaka O; Yamauchi S; Kawamura K; Matsuura S; Nishimura M; Iwaki N; Kashiwagi S Clin Infect Dis; 2009 Dec; 49(12):1828-35. PubMed ID: 19911968 [TBL] [Abstract][Full Text] [Related]
18. Binding interaction analysis of the active site and its inhibitors for neuraminidase (N1 subtype) of human influenza virus by the integration of molecular docking, FMO calculation and 3D-QSAR CoMFA modeling. Zhang Q; Yang J; Liang K; Feng L; Li S; Wan J; Xu X; Yang G; Liu D; Yang S J Chem Inf Model; 2008 Sep; 48(9):1802-12. PubMed ID: 18707092 [TBL] [Abstract][Full Text] [Related]
19. Susceptibility of antiviral drugs against 2009 influenza A (H1N1) virus. Rungrotmongkol T; Intharathep P; Malaisree M; Nunthaboot N; Kaiyawet N; Sompornpisut P; Payungporn S; Poovorawan Y; Hannongbua S Biochem Biophys Res Commun; 2009 Jul; 385(3):390-4. PubMed ID: 19463784 [TBL] [Abstract][Full Text] [Related]
20. Characterization of human H1N1 influenza virus variants selected in vitro with zanamivir in the presence of sialic acid-containing molecules. Giannecchini S; Campitelli L; Bandini G; Donatelli I; Azzi A Virus Res; 2007 Nov; 129(2):241-5. PubMed ID: 17765996 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]